ICON Plc shares plunged after the health care services contractor said it may have overstated some of its past revenue and pulled its guidance for the year.

Preliminary findings of a probe initiated last year found that 2023 and 2024 revenue may have been overstated by “less than 2%” for each fiscal year, according to a Thursday statement from the US-listed ICON.